Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with Cognition or Healthy Participants. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at examine how the human thalamus supports flexible thinking and behavior for people with Schizophrenia or Attention Deficit Disorder With Hyperactivity. Some participants may receive Within subject manipulation of working memory, cognitive control, and decision making instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing repetitive transcranial magnetic stimulation (active) with sham rTMS for people with Schizophrenia. Participants receive repetitive transcranial magnetic stimulation (active) or sham rTMS and complete study visits and assessments.
This study is comparing Emraclidine with placebo for people with Schizophrenia. Participants receive Emraclidine or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive active, then sham Intermittent Theta Burst Stimulation (iTBS) over DLPFC instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether PEERS social skills intervention can help people with Autism Spectrum Disorder, Psychosis, or Social Communication. Participants take part in PEERS social skills intervention and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is comparing Evenamide 15 mg bid with placebo for people with Treatment-resistant Schizophrenia. Participants receive Evenamide 15 mg bid or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia and Other psychosis, Cannabis Use Disorder, or Healthy to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Schizophrenia or schizoaffective disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing iTEST with Active Control for people with Schizophrenia Disorders, schizoaffective disorder, or psychosis. Participants receive iTEST or Active Control and complete study visits and assessments.
This study is comparing LB-102 (50 mg tablet) with placebo for people with Schizophrenia. Participants receive LB-102 (50 mg tablet) or placebo and complete study visits and assessments.
This observational study is following people with Healthy Participants or Schizophrenia Diagnosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing iloperidone with placebo for people with Schizophrenia. Participants receive iloperidone or placebo and complete study visits and assessments.
This observational study is following people with Smoking Cessation, Nicotine Addiction, or Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive iTBS, then Sham instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Cannabidiol oral solution with placebo for people with Early Psychosis. Participants receive Cannabidiol oral solution or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Cognitive Impairment. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether cognitive behavioural therapy can help people with Clinical High Risk for Psychosis or Ultra High Risk for Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This study is looking at whether SCORES (Specific COgnitive Remediation with Support) can help people with Psychosis, Prodromal Schizophrenia, or Prodromal Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing MI-CBTech with Mindfulness control for people with psychosis. Participants receive MI-CBTech or Mindfulness control and complete study visits and assessments.